查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1563890

連續血糖監測系統的全球市場

Continuous Glucose Monitoring Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 202 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球連續血糖監測系統市場將達到 103 億美元

預計 2023 年全球連續血糖監測系統市場規模為 36 億美元，預計到 2030 年將達到 103 億美元，2023-2030 年分析期間複合年成長率為 15.9%。感測器組件是本報告分析的細分市場之一，預計複合年成長率為 14.7%，到分析期結束時將達到 54 億美元。在分析期間，發射器和接收器組件領域預計將以 16.8% 的複合年成長率成長。

美國市場預估價值9.651億美元，中國預期複合年成長率為22.5%

預計 2023 年美國連續血糖監測系統市場規模將達 9.651 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達28億美元，2023-2030年分析期間複合年成長率為22.5%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 12.2% 和 13.0%。在歐洲，德國預計複合年成長率為 12.3%。

全球連續血糖監測系統市場—主要趨勢與促進因素總結

連續血糖監測系統如何徹底改變糖尿病管理？

連續血糖監測 (CGM) 系統透過即時了解血糖濃度，實現更好的血糖控制和更明智的治療決策，正在徹底改變糖尿病管理。與傳統的指尖採血方法不同，CGM 設備透過插入皮下的感測器連續測量血糖濃度，提供可透過智慧型手機或專用讀取器存取的資料。這項技術進步極大地提高了追蹤血糖值模式和趨勢的能力，使患者和醫療保健提供者能夠更有效地調整治療計劃。 CGM 系統提供的便利性和準確性對於需要精確胰島素劑量的 1 型糖尿病患者尤其重要。此外，由於人口老化、久坐的生活方式和肥胖率上升等因素，全球糖尿病盛行率不斷上升，這增加了對這些先進監測系統的需求。

哪些技術創新將塑造 CGM 設備的未來？

連續血糖監測系統市場由多項技術創新推動，這些技術創新提高了設備精度、使用者體驗和資料分析能力。更小、更舒適、佩戴時間更長、校準次數更少的感測器的開發顯著提高了患者的依從性和滿意度。新一代 CGM 系統正在與胰島素幫浦整合，以創建閉合迴路系統或「人工胰臟」設置，可根據即時血糖測量自動進行胰島素管理。藍牙技術和智慧型手機應用程式整合的進步使用戶能夠輕鬆地與看護者和醫療保健提供者共用血糖資料，從而促進更好的糖尿病管理。此外，還採用預測分析和基於人工智慧的演算法來預測潛在的血糖水平趨勢，並提供警報以預防高血糖或低血糖。這些技術進步不僅提高了 CGM 系統的有效性，而且使糖尿病管理更加主動和個人化。

監管核准和報銷政策如何影響 CGM 市場？

監管部門的核准和優惠的報銷政策是推動連續血糖監測系統市場擴張的關鍵因素。近年來，美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構已經認知到它們在改善患者治療效果和降低醫療成本方面的潛力，並加速了新型 CGM 設備的核准。這些監管核准增強了醫療保健提供者和患者對 CGM 系統安全性和有效性的信心。此外，一些國家的保險公司和政府醫療保健計劃正在擴大 CGM 設備的覆蓋範圍，使更多的糖尿病人群能夠使用它們。 CGM 系統擴大納入健康保險報銷計劃，是實現更廣泛採用和使用的關鍵因素，特別是在需要持續監測的老年人和 1 型糖尿病患者中。

推動連續血糖監測系統市場成長的因素有哪些？

連續血糖監測系統市場的成長受到多種因素的推動，例如糖尿病盛行率上升、技術進步以及支持性監管和報銷框架。主要促進因素之一是患者和醫療保健提供者越來越意識到即時血糖監測對於實現更好的血糖控制的好處。與數位健康平台和行動應用程式的整合也推動了 CGM 系統的普及，從而提高了用戶參與度和資料驅動的見解。此外，醫療保健行業向基於價值的護理的轉變正在推動 CGM 系統的使用，作為減少糖尿病相關併發症和整體醫療保健成本的一種手段。此外，CGM 設備製造商和數位健康公司之間的策略聯盟正在推動市場發展，透過資料分析和人工智慧擴展這些設備的功能。這些因素共同促成了全球 CGM 市場的強勁成長前景。

受訪企業範例（53家知名企業）

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP15797

Global Continuous Glucose Monitoring Systems Market to Reach US$10.3 Billion by 2030

The global market for Continuous Glucose Monitoring Systems estimated at US$3.6 Billion in the year 2023, is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Transmitters & Receivers Component segment is estimated at 16.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$965.1 Million While China is Forecast to Grow at 22.5% CAGR

The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$965.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 22.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Continuous Glucose Monitoring Systems Market - Key Trends & Drivers Summarized

How Are Continuous Glucose Monitoring Systems Revolutionizing Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are revolutionizing the management of diabetes by providing real-time insights into glucose levels, allowing for better glycemic control and more informed treatment decisions. Unlike traditional finger-prick methods, CGM devices continuously measure glucose levels through a sensor inserted under the skin, offering data that can be accessed via smartphones or dedicated readers. This technological advancement significantly enhances the ability to track blood glucose patterns and trends, enabling patients and healthcare providers to tailor treatment plans more effectively. The convenience and accuracy provided by CGM systems are especially crucial for patients with Type 1 diabetes, who require precise insulin dosing. Furthermore, the increasing prevalence of diabetes globally, driven by factors such as aging populations, sedentary lifestyles, and rising obesity rates, is amplifying the demand for these advanced monitoring systems.

What Technological Innovations Are Shaping The Future Of CGM Devices?

The Continuous Glucose Monitoring systems market is being propelled by several technological innovations that are enhancing device accuracy, user experience, and data analytics capabilities. The development of smaller, more comfortable sensors that provide longer wear times and require fewer calibrations is significantly improving patient adherence and satisfaction. Next-generation CGM systems are integrating with insulin pumps, creating closed-loop systems or “artificial pancreas” setups that automate insulin delivery based on real-time glucose readings. Advances in Bluetooth technology and smartphone app integrations are allowing users to easily share their glucose data with caregivers and healthcare providers, promoting better diabetes management. Furthermore, predictive analytics and AI-based algorithms are being employed to forecast potential glucose level trends, providing alerts to prevent hyperglycemia or hypoglycemia. These technological advancements are not only enhancing the effectiveness of CGM systems but are also making diabetes management more proactive and personalized.

How Are Regulatory Approvals And Reimbursement Policies Impacting The CGM Market?

Regulatory approvals and favorable reimbursement policies are crucial factors driving the expansion of the Continuous Glucose Monitoring systems market. In recent years, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have fast-tracked approvals for new CGM devices, recognizing their potential to improve patient outcomes and reduce healthcare costs. These regulatory endorsements have instilled greater confidence among healthcare providers and patients regarding the safety and efficacy of CGM systems. Additionally, insurance companies and government healthcare programs in several countries are expanding their coverage for CGM devices, making them more accessible to a larger segment of the diabetic population. The increasing inclusion of CGM systems in health insurance reimbursement plans is a key factor enabling broader adoption and use, particularly among the elderly and those with Type 1 diabetes who require constant monitoring.

What Factors Are Driving The Growth Of The Continuous Glucose Monitoring Systems Market?

The growth in the Continuous Glucose Monitoring systems market is driven by several factors, including rising diabetes prevalence, technological advancements, and supportive regulatory and reimbursement frameworks. One of the key drivers is the increasing awareness among patients and healthcare providers about the benefits of real-time glucose monitoring for achieving better glycemic control. The growing adoption of CGM systems is also being fueled by their integration with digital health platforms and mobile applications, which offer enhanced user engagement and data-driven insights. Additionally, the shift toward value-based care in the healthcare industry is promoting the use of CGM systems as a means to reduce diabetes-related complications and overall healthcare costs. Further driving the market are strategic partnerships between CGM device manufacturers and digital health companies, which are expanding the capabilities of these devices through data analytics and artificial intelligence. These factors collectively contribute to the robust growth outlook for the CGM market worldwide.

Select Competitors (Total 53 Featured) -

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Continuous Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Diabetes and Need for Continuous Monitoring
    • Technological Advancements in CGM Device Accuracy and Connectivity
    • Rising Adoption of Wearable Health Monitoring Devices
    • Growing Demand for Non-Invasive Glucose Monitoring Solutions
    • Integration of CGM with Digital Health Platforms and Apps
    • Development of AI-Based Predictive Analysis in Diabetes Management
    • Increasing Awareness and Adoption Among Non-Diabetic Users
    • Expanding Availability of CGM Devices in Emerging Markets
    • Government Reimbursement Policies Supporting CGM Adoption
    • Innovations in Miniaturized and Implantable Glucose Sensors
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Continuous Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transmitters & Receivers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Integrated Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • INDIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AFRICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030

IV. COMPETITION